|
Solvent |
mg/mL |
mM |
comments |
| Solubility |
| DMSO |
73.0 |
317.03 |
|
| Ethanol |
46.0 |
199.77 |
|
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.
Preparing Stock Solutions
The following data is based on the
product
molecular weight
230.26
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Oode C, Shimada W, Izutsu Y, Yokota M, Iwadate T, Nihei K. Synthesis of dihydroresveratrol glycosides and evaluation of their activity against melanogenesis in B16F0 melanoma cells. Eur J Med Chem. 2014 Nov 24;87:862-7. doi: 10.1016/j.ejmech.2014.09.092. Epub 2014 Oct 2. PubMed PMID: 25440886.
2: Radko Y, Christensen KB, Christensen LP. Semi-preparative isolation of dihydroresveratrol-3-O-β-d-glucuronide and four resveratrol conjugates from human urine after oral intake of a resveratrol-containing dietary supplement. J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Jul 1;930:54-61. doi: 10.1016/j.jchromb.2013.05.002. Epub 2013 May 7. PubMed PMID: 23727867.
3: Faragher RG, Burton DG, Majecha P, Fong NS, Davis T, Sheerin A, Ostler EL. Resveratrol, but not dihydroresveratrol, induces premature senescence in primary human fibroblasts. Age (Dordr). 2011 Dec;33(4):555-64. doi: 10.1007/s11357-010-9201-5. Epub 2011 Feb 12. PubMed PMID: 21318333; PubMed Central PMCID: PMC3220406.
4: Oode C, Shimada W, Yokota M, Yamada Y, Nihei KI. Dihydroresveratrol cellobioside and xylobioside as effective melanogenesis activators. Carbohydr Res. 2016 Dec 21;436:45-49. doi: 10.1016/j.carres.2016.11.004. Epub 2016 Nov 9. PubMed PMID: 27863303.
5: Juan ME, Alfaras I, Planas JM. Determination of dihydroresveratrol in rat plasma by HPLC. J Agric Food Chem. 2010 Jun 23;58(12):7472-5. doi: 10.1021/jf100836j. PubMed PMID: 20509689.
6: Xie CF, Yuan HQ, Qu JB, Xing J, Lü BB, Wang XN, Ji M, Lou HX. Biocatalytic production of acyclic bis[bibenzyls] from dihydroresveratrol by crude Momordica charantia peroxidase. Chem Biodivers. 2009 Aug;6(8):1193-201. doi: 10.1002/cbdv.200800229. PubMed PMID: 19697337.
7: Lin ZS, Ku CF, Guan YF, Xiao HT, Shi XK, Wang HQ, Bian ZX, Tsang SW, Zhang HJ. Dihydro-Resveratrol Ameliorates Lung Injury in Rats with Cerulein-Induced Acute Pancreatitis. Phytother Res. 2016 Apr;30(4):663-70. doi: 10.1002/ptr.5576. Epub 2016 Feb 1. PubMed PMID: 26833708.
8: Tsang SW, Guan YF, Wang J, Bian ZX, Zhang HJ. Inhibition of pancreatic oxidative damage by stilbene derivative dihydro-resveratrol: implication for treatment of acute pancreatitis. Sci Rep. 2016 Mar 14;6:22859. doi: 10.1038/srep22859. PubMed PMID: 26971398; PubMed Central PMCID: PMC4789643.
9: Anisimova NY, Kiselevsky MV, Sosnov AV, Sadovnikov SV, Stankov IN, Gakh AA. Trans-, cis-, and dihydro-resveratrol: a comparative study. Chem Cent J. 2011 Dec 20;5:88. doi: 10.1186/1752-153X-5-88. PubMed PMID: 22185600; PubMed Central PMCID: PMC3313904.
10: Vitalini S, Cicek SS, Granica S, Zidorn C. Dihydroresveratrol Type Dihydrostilbenoids: Chemical Diversity, Chemosystematics, and Bioactivity. Curr Med Chem. 2018;25(10):1194-1240. doi: 10.2174/0929867324666170830112343. PubMed PMID: 28875843.
